As of Jul 2023 ยท from IZOLA Common Stock Round 2023 ยท pre-money + amount raised, not a traded price
Total raised
$2,139,500
Across 5 rounds since 2022
Latest share price
$2.00
IZOLA Common Stock Round 2023 offering price
Financials
FY2019โFY2025 ยท from SEC filings ยท hover any figure for its source
$0
$13K
2019
$136K
โ$84K
2020
$351K
โ$131K
2021
$1.1M
โ$248K
2022
$1.6M
โ$310K
2023
$1.4M
โ$595K
2024
$3.1M
$273K
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$135,774
$351,183
$1,093,519
$1,647,324
$1,399,675
$3,085,824
Cost of goods sold
$52,336
$42,169
$127,633
$753,837
$891,308
$369,234
$644,807
Gross margin
โ
69%
64%
31%
46%
74%
79%
Net income
$12,704
-$84,373
-$131,065
-$248,031
-$309,560
-$594,541
$272,687
Taxes paid
$3,432
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$32,977
$45,353
$100,204
$348,900
$604,726
$324,945
$371,336
Accounts receivable
$0
$0
$0
$0
$98,497
$0
$0
Total assets
$50,864
$73,421
$210,734
$2,300,830
$2,769,655
$4,933,173
$5,248,707
Short-term debt
$0
$8,951
$66,934
$245,677
$256,880
$516,312
$462,229
Long-term debt
$0
$128,029
$304,392
$2,021,353
$1,961,221
$3,146,549
$2,891,202
Total liabilities
$0
$136,980
$371,326
$2,267,030
$2,218,101
$3,662,861
$3,353,431
Other
Headcount
โ
11
30
45
45
43
42
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.